Display options
Cite
Provazzi PJ, Arcuri HA, de Carvalho-Mello IM, et al. Structural studies of Helicase NS3 variants from Hepatitis C virus genotype 3 in virological sustained responder and non-responder patients. BMC Res Notes. 2010;3:196doi: 10.1186/1756-0500-3-196.
Provazzi, P. J., Arcuri, H. A., de Carvalho-Mello, I. M., Pinho, J. R., Nogueira, M. L., Palma, M. S., & Rahal, P. (2010). Structural studies of Helicase NS3 variants from Hepatitis C virus genotype 3 in virological sustained responder and non-responder patients. BMC research notes, 3196. https://doi.org/10.1186/1756-0500-3-196
Provazzi, Paola Js, et al. "Structural studies of Helicase NS3 variants from Hepatitis C virus genotype 3 in virological sustained responder and non-responder patients." BMC research notes vol. 3 (2010): 196. doi: https://doi.org/10.1186/1756-0500-3-196
Provazzi PJ, Arcuri HA, de Carvalho-Mello IM, Pinho JR, Nogueira ML, Palma MS, Rahal P. Structural studies of Helicase NS3 variants from Hepatitis C virus genotype 3 in virological sustained responder and non-responder patients. BMC Res Notes. 2010 Jul 14;3:196. doi: 10.1186/1756-0500-3-196. PMID: 20630078; PMCID: PMC2919562.
Copy Download .nbib Format: NLM
Share it on

BMC Res Notes. 2010 Jul 14;3:196. doi: 10.1186/1756-0500-3-196.

Structural studies of Helicase NS3 variants from Hepatitis C virus genotype 3 in virological sustained responder and non-responder patients.

BMC research notes

Paola Js Provazzi, Helen A Arcuri, Isabel Maria Vg de Carvalho-Mello, João Renato R Pinho, Maurício L Nogueira, Mário S Palma, Paula Rahal

Affiliations

  1. São Paulo State University - UNESP, Department of Biology, São José do Rio Preto/SP, CEP: 15054-000, Brazil. [email protected].

PMID: 20630078 PMCID: PMC2919562 DOI: 10.1186/1756-0500-3-196

Abstract

BACKGROUND: About 130 million people are infected with the hepatitis C virus (HCV) worldwide, but effective treatment options are not yet available. One of the most promising targets for antiviral therapy is nonstructural protein 3 (NS3). To identify possible changes in the structure of NS3 associated with virological sustained response or non-response of patients, a model was constructed for each helicase NS3 protein coding sequence. From this, the goal was to verify the interaction between helicases variants and their ligands.

FINDINGS: Evidence was found that the NS3 helicase portion of non-responder patients contained substitutions in its ATP and RNA binding sites. K210E substitution can cause an imbalance in the distribution of loads, leading to a decrease in the number of ligations between the essential amino acids required for the hydrolysis of ATP. W501R substitution causes an imbalance in the distribution of loads, leading and forcing the RNA to interact with the amino acid Thr269, but not preventing binding of ribavirin inhibitor.

CONCLUSIONS: Useful information is provided on the genetic profiling of the HCV genotype 3, specifically the coding region of the NS3 protein, improving our understanding of the viral genome and the regions of its protein catalytic site.

References

  1. J Virol. 1997 Dec;71(12):9400-9 - PubMed
  2. N Engl J Med. 2001 Jul 5;345(1):41-52 - PubMed
  3. Curr Issues Mol Biol. 2007 Jan;9(1):1-20 - PubMed
  4. J Virol. 2000 Oct;74(20):9732-7 - PubMed
  5. J Mol Graph. 1990 Mar;8(1):52-6, 29 - PubMed
  6. Nature. 1992 Mar 5;356(6364):83-5 - PubMed
  7. Structure. 1998 Jan 15;6(1):89-100 - PubMed
  8. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9524-8 - PubMed
  9. J Virol. 1991 Mar;65(3):1105-13 - PubMed
  10. J Virol. 1993 Aug;67(8):4665-75 - PubMed
  11. EMBO J. 1982;1(8):945-51 - PubMed
  12. J Mol Biol. 1993 Dec 5;234(3):779-815 - PubMed
  13. Science. 1989 Apr 21;244(4902):359-62 - PubMed
  14. J Med Chem. 2006 Jun 1;49(11):3315-21 - PubMed

Publication Types